tiprankstipranks
Sotera Health (DE:SH5)
MUNICH:SH5
Germany Market

Sotera Health (SH5) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

SH5 Analyst Ratings

Strong Buy
7Ratings
Strong Buy
6 Buy
1 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Sotera
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SH5 Stock 12 Month Forecast

Average Price Target

€19.56
▲(17.11% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Sotera Health in the last 3 months. The average price target is €19.56 with a high forecast of €21.39 and a low forecast of €15.40. The average price target represents a 17.11% change from the last price of €16.70.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"8":"€8","15":"€15","22":"€22","11.5":"€11.5","18.5":"€18.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":21.39009975,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€21.39</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19.556662628571427,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€19.56</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.40087182,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€15.40</span>\n  </div></div>","useHTML":true}}],"tickPositions":[8,11.5,15,18.5,22],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.6,16.04539228846154,16.490784576923076,16.936176865384617,17.381569153846154,17.82696144230769,18.272353730769233,18.71774601923077,19.163138307692307,19.608530596153848,20.053922884615385,20.499315173076923,20.944707461538464,{"y":21.39009975,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.6,15.904358663736263,16.208717327472527,16.51307599120879,16.817434654945053,17.121793318681316,17.426151982417583,17.730510646153846,18.03486930989011,18.33922797362637,18.643586637362635,18.947945301098898,19.252303964835164,{"y":19.556662628571427,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.6,15.584682447692307,15.569364895384615,15.554047343076922,15.538729790769231,15.523412238461539,15.508094686153846,15.492777133846154,15.477459581538461,15.462142029230769,15.446824476923078,15.431506924615386,15.416189372307693,{"y":15.40087182,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":9.55,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.8,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.5,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.9,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.1,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.2,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.6,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.4,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.1,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.4,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.5,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.6,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€21.39Average Price Target€19.56Lowest Price Target€15.40
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on DE:SH5
J.P. Morgan
J.P. Morgan
€15.4
Hold
-7.78%
Downside
Reiterated
08/10/26
J.P. Morgan Sticks to Their Hold Rating for Sotera Health (SHC)
Barclays Analyst forecast on DE:SH5
Barclays
Barclays
€16.26€18.82
Buy
12.71%
Upside
Reiterated
08/07/26
Analysts Are Bullish on Top Healthcare Stocks: Genmab (GMAB), Sotera Health (SHC)
Citi
€19.68€21.39
Buy
28.08%
Upside
Reiterated
08/07/26
Citi Sticks to Its Buy Rating for Sotera Health (SHC)
Piper Sandler Analyst forecast on DE:SH5
Piper Sandler
Piper Sandler
€18.82€21.39
Buy
28.08%
Upside
Reiterated
08/07/26
Sotera Health (SHC) Gets a Buy from Piper Sandler
RBC Capital Analyst forecast on DE:SH5
RBC Capital
RBC Capital
€20.53
Buy
22.96%
Upside
Reiterated
08/06/26
RBC Capital Reaffirms Their Buy Rating on Sotera Health (SHC)
Goldman Sachs Analyst forecast on DE:SH5
Goldman Sachs
Goldman Sachs
€18.82€20.53
Buy
22.96%
Upside
Reiterated
08/06/26
Sotera Health Earns Buy Rating as Strong Q2 Beat, Raised Guidance, and Higher $24 Price Target Highlight Durable, Capacity-Driven Growth
BMO Capital Analyst forecast on DE:SH5
BMO Capital
BMO Capital
€17.11€18.82
Buy
12.71%
Upside
Assigned
08/06/26
Sotera Health (SHC) Receives a Buy from BMO Capital
Jefferies Analyst forecast on DE:SH5
Jefferies
Jefferies
€16.68
Buy
-0.09%
Downside
Reiterated
11/20/25
Jefferies Keeps Their Buy Rating on Sotera Health (SHC)
KeyBanc
Hold
Reiterated
11/05/25
Sotera Health (SHC) Receives a Hold from KeyBanc
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on DE:SH5
J.P. Morgan
J.P. Morgan
€15.4
Hold
-7.78%
Downside
Reiterated
08/10/26
J.P. Morgan Sticks to Their Hold Rating for Sotera Health (SHC)
Barclays Analyst forecast on DE:SH5
Barclays
Barclays
€16.26€18.82
Buy
12.71%
Upside
Reiterated
08/07/26
Analysts Are Bullish on Top Healthcare Stocks: Genmab (GMAB), Sotera Health (SHC)
Citi
€19.68€21.39
Buy
28.08%
Upside
Reiterated
08/07/26
Citi Sticks to Its Buy Rating for Sotera Health (SHC)
Piper Sandler Analyst forecast on DE:SH5
Piper Sandler
Piper Sandler
€18.82€21.39
Buy
28.08%
Upside
Reiterated
08/07/26
Sotera Health (SHC) Gets a Buy from Piper Sandler
RBC Capital Analyst forecast on DE:SH5
RBC Capital
RBC Capital
€20.53
Buy
22.96%
Upside
Reiterated
08/06/26
RBC Capital Reaffirms Their Buy Rating on Sotera Health (SHC)
Goldman Sachs Analyst forecast on DE:SH5
Goldman Sachs
Goldman Sachs
€18.82€20.53
Buy
22.96%
Upside
Reiterated
08/06/26
Sotera Health Earns Buy Rating as Strong Q2 Beat, Raised Guidance, and Higher $24 Price Target Highlight Durable, Capacity-Driven Growth
BMO Capital Analyst forecast on DE:SH5
BMO Capital
BMO Capital
€17.11€18.82
Buy
12.71%
Upside
Assigned
08/06/26
Sotera Health (SHC) Receives a Buy from BMO Capital
Jefferies Analyst forecast on DE:SH5
Jefferies
Jefferies
€16.68
Buy
-0.09%
Downside
Reiterated
11/20/25
Jefferies Keeps Their Buy Rating on Sotera Health (SHC)
KeyBanc
Hold
Reiterated
11/05/25
Sotera Health (SHC) Receives a Hold from KeyBanc
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ODTXOdyssey Therapeutics, Inc.
BTSGBrightSpring Health Services, Inc.
GPCRStructure Therapeutics, Inc. Sponsored ADR
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sotera Health

3 Months
Luke SergottBarclays
Success Rate
19/32 ratings generated profit
59%
Average Return
-3.76%
Copying Luke Sergott's trades and holding each position for 3 Months would result in 59.38% of your transactions generating a profit, with an average return of -3.76% per trade.
1 Year
David WindleyJefferies
Success Rate
6/12 ratings generated profit
50%
Average Return
+4.23%
Copying David Windley's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +4.23% per trade.
2 Years
David WindleyJefferies
Success Rate
9/12 ratings generated profit
75%
Average Return
+20.13%
Copying David Windley's trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +20.13% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SH5 Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
2
4
3
2
0
Buy
11
8
11
10
11
Hold
0
0
1
1
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
12
15
13
13
In the current month, SH5 has received 11 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. SH5 average Analyst price target in the past 3 months is 19.56.
Each month's total comprises the sum of three months' worth of ratings.

SH5 Financial Forecast

SH5 Earnings Forecast

Next quarter’s earnings estimate for SH5 is €0.23 with a range of €0.23 to €0.23. The previous quarter’s EPS was €0.23. SH5 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year SH5 has Performed in-line its overall industry.
Next quarter’s earnings estimate for SH5 is €0.23 with a range of €0.23 to €0.23. The previous quarter’s EPS was €0.23. SH5 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year SH5 has Performed in-line its overall industry.

SH5 Sales Forecast

Next quarter’s sales forecast for SH5 is €277.20M with a range of €274.74M to €281.34M. The previous quarter’s sales results were €278.54M. SH5 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year SH5 has Performed in-line its overall industry.
Next quarter’s sales forecast for SH5 is €277.20M with a range of €274.74M to €281.34M. The previous quarter’s sales results were €278.54M. SH5 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year SH5 has Performed in-line its overall industry.

SH5 Stock Forecast FAQ

What is DE:SH5’s average 12-month price target, according to analysts?
Based on analyst ratings, Sotera Health’s 12-month average price target is 19.56.
    What is DE:SH5’s upside potential, based on the analysts’ average price target?
    Sotera Health has 17.11% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Sotera Health a Buy, Sell or Hold?
          Sotera Health has a consensus rating of Strong Buy, which is based on 6 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Sotera Health’s share price target?
            The average share price target for Sotera Health is 19.56. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €21.39 ,and the lowest forecast is €15.40. The average share price target represents 17.11% Increase from the current price of €16.7.
              What do analysts say about Sotera Health?
              Sotera Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of Sotera Health?
                To buy shares of DE:SH5, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.